{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:18:05Z","timestamp":1762507085787},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,6,20]]},"DOI":"10.18632\/oncotarget.17068","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T15:52:15Z","timestamp":1492012335000},"page":"41143-41153","source":"Crossref","is-referenced-by-count":17,"title":["Androgen receptor status predicts development of brain metastases in ovarian cancers"],"prefix":"10.18632","volume":"8","author":[{"given":"Gloria","family":"Mittica","sequence":"first","affiliation":[{"name":"Department of Oncology, University of Turin, Turin, Italy"},{"name":"Division of Medical Oncology-1, Candiolo Cancer Institute-FPO- IRCCS, Candiolo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Senetta","sequence":"additional","affiliation":[{"name":"Unit of Pathology Candiolo Cancer Institute-FPO- IRCCS, Candiolo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Scotto","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Aglietta","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin, Turin, Italy"},{"name":"Division of Medical Oncology-1, Candiolo Cancer Institute-FPO- IRCCS, Candiolo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furio","family":"Maggiorotto","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Candiolo Cancer Institute-FPO- IRCCS, Candiolo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Ghisoni","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin, Turin, Italy"},{"name":"Division of Medical Oncology-1, Candiolo Cancer Institute-FPO- IRCCS, Candiolo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Genta","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin, Turin, Italy"},{"name":"Division of Medical Oncology-1, Candiolo Cancer Institute-FPO- IRCCS, Candiolo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzo","family":"Boldorini","sequence":"additional","affiliation":[{"name":"Department of Health Science, University of Eastern Piedmont \u201cAmedeo Avogadro\u201d, Novara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Manini","sequence":"additional","affiliation":[{"name":"Unit of Pathology, Giovanni Bosco Hospital, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Morra","sequence":"additional","affiliation":[{"name":"Unit of Pathology, Citt\u00e0 della Salute e della Scienza, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Buosi","sequence":"additional","affiliation":[{"name":"Division of Oncology, Santo Spirito Hospital, Casale Monferrato, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sapino","sequence":"additional","affiliation":[{"name":"Unit of Pathology Candiolo Cancer Institute-FPO- IRCCS, Candiolo, Italy"},{"name":"Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Cassoni","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Valabrega","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin, Turin, Italy"},{"name":"Division of Medical Oncology-1, Candiolo Cancer Institute-FPO- IRCCS, Candiolo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Jemal","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/ijgc-00009577-200303000-00004","article-title":"Distant metastases in ovarian carcinoma","volume":"13","author":"Selvaggi","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"527453","DOI":"10.5402\/2011\/527453","article-title":"Brain metastases from ovarian carcinoma","volume":"2011","author":"Piura","year":"2011","journal-title":"ISRN Oncol"},{"key":"4","first-page":"3553","article-title":"Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature","volume":"25","author":"Dimopoulos","year":"2005","journal-title":"Anticancer Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0090-8258(89)90515-5","article-title":"Cerebral metastases in patients with ovarian cancer treated with chemotherapy","volume":"33","author":"Harvey","year":"1989","journal-title":"Gynecol Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/B:NEON.0000014516.04943.38","article-title":"Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome","volume":"66","author":"Sawaya","year":"2004","journal-title":"J Neurooncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1200\/JCO.2002.20.4.982","article-title":"Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence","volume":"20","author":"Gore","year":"2002","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1634\/theoncologist.11-3-252","article-title":"Brain metastases from epithelial ovarian cancer: a review of the literature","volume":"11","author":"Economopoulos","year":"2006","journal-title":"Oncologist"},{"key":"9","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/j.1525-1438.2007.00941.x","article-title":"Prognostic factors associated with brain metastases from epithelial ovarian carcinoma","volume":"17","author":"Kim","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/IGC.0b013e318216cad0","article-title":"Central nervous system metastases from epithelial ovarian cancer: prognostic factors and outcomes","volume":"21","author":"Selvaggi","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/j.1525-1438.2006.00596.x","article-title":"Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy","volume":"16","author":"Bamias","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ygyno.2012.11.001","article-title":"Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial)","volume":"128","author":"Shimada","year":"2013","journal-title":"Gynecol Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-014-1447-9","article-title":"Brain metastasis from ovarian cancer: a systematic review","volume":"119","author":"Jabbari","year":"2014","journal-title":"J Neurooncol"},{"key":"14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ygyno.2016.09.025","article-title":"Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)","volume":"143","author":"Scollo","year":"2016","journal-title":"Gynecol Oncol"},{"key":"15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4137\/CMO.S32813","article-title":"Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations","volume":"10","author":"Voutsadakis","year":"2016","journal-title":"Clin Med Insights Oncol"},{"key":"16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ygyno.2004.11.010","article-title":"Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer","volume":"96","author":"Liu","year":"2005","journal-title":"Gynecol Oncol"},{"key":"17","first-page":"1051","article-title":"Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the \u2019MALOVA\u2019 ovarian cancer study","volume":"18","author":"Kjaer","year":"2007","journal-title":"Oncol Rep"},{"key":"18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12253-010-9340-0","article-title":"Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival","volume":"17","author":"Surowiak","year":"2011","journal-title":"Pathol Oncol Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/1471-2407-12-553","article-title":"Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival","volume":"12","author":"Jeschke","year":"2012","journal-title":"BMC Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1471-2407-13-115","article-title":"The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer","volume":"13","author":"Polterauer","year":"2013","journal-title":"BMC Cancer"},{"key":"21","first-page":"125","article-title":"Clinical significance of hormonal receptor status of malignant ovarian tumors","volume":"36","author":"Chekhun","year":"2014","journal-title":"Exp Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ygyno.2015.06.032","article-title":"Hormone receptors as a marker of poor survival in epithelial ovarian cancer","volume":"138","author":"Reyners","year":"2015","journal-title":"Gynecol Oncol"},{"key":"23","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Love","year":"2010","journal-title":"J Clin Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10549-010-0761-y","article-title":"Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers","volume":"124","author":"Sapino","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"25","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.7314\/APJCP.2014.15.22.9739","article-title":"Hormone receptor, HER2\/NEU and EGFR expression in ovarian carcinoma--is here a prognostic phenotype?","volume":"15","author":"Tarhan","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1757-2215-3-14","article-title":"Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival","volume":"3","author":"Jirstr\u00f6m","year":"2010","journal-title":"J Ovarian Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tranon.2015.09.002","article-title":"Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival","volume":"8","author":"Hedenfalk","year":"2015","journal-title":"Transl Oncol"},{"key":"28","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Mangu","year":"2013","journal-title":"J Clin Oncol"},{"key":"29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1447-0756.2012.01961.x","article-title":"Increased incidence of brain metastases in BRCA1-related ovarian cancers","volume":"39","author":"Tanaka","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/COC.0b013e3181ec5f4b","article-title":"Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer","volume":"34","author":"Sood","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/IGC.0b013e3182788466","article-title":"Prognostic role of hormone receptors in ovarian cancer: a systematic review and meta-analysis","volume":"23","author":"Sun","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"33","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1172\/JCI68509","article-title":"Predicting time to ovarian carcinoma recurrence using protein markers","volume":"123","author":"Verhaak","year":"2013","journal-title":"J Clin Invest"},{"key":"34","doi-asserted-by":"publisher","first-page":"e82650","DOI":"10.1371\/journal.pone.0082650","article-title":"The impact of androgen receptor expression on breast cancer survival: a retrospective study and meta-analysis","volume":"8","author":"Shen","year":"2013","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/bjc.2016.16","article-title":"Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival","volume":"114","author":"Hapangama","year":"2016","journal-title":"Br J Cancer"},{"key":"36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000086958","article-title":"HER2\/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance","volume":"68","author":"Boccardo","year":"2005","journal-title":"Clinical study Oncology"},{"key":"37","doi-asserted-by":"publisher","first-page":"e2803","DOI":"10.1097\/MD.0000000000002803","article-title":"Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer","volume":"95","author":"Xu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s13577-012-0053-4","article-title":"Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies","volume":"26","author":"Suzuki","year":"2013","journal-title":"Hum Cell"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T19:57:58Z","timestamp":1589140678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":38,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,6,20]]}},"alternative-id":["17068","28467804"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17068","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,12]]}}}